Recommended Cash Acquisition of Clinigen Group plc
This announcement is not an offer, whether directly or indirectly, in any jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. You are attempting to enter the area of this website that is designated for the publication of documents and information in connection with the proposed offer pursuant to which funds advised by Triton Investment Management Limited (“Triton”) may acquire the entire issued share capital of Clinigen Group plc (“Clinigen”) (the “Offer”) to be implemented by way of a scheme of arrangement. The information contained in this area of the website is made available in good faith and for information purposes only and is subject to the terms and conditions set out below. In particular, the information contained in this area of the website does not constitute an offer to sell or otherwise dispose of or any invitation or solicitation of any offer to purchase or subscribe for any securities pursuant to the Offer or otherwise in any jurisdiction in which such offer or solicitation is unlawful. All persons resident or located outside the United Kingdom who wish to view this area of the website must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so and should inform themselves of, and observe, any applicable legal or regulatory requirements applicable in their jurisdiction. If you are resident or located in a country that renders the accessing of this area of the website or parts thereof illegal, whether or not subject to making certain notifications or taking other action, you should not view this area of the website.
Recommended Cash Acquisition of Clinigen Group plc
The board of directors of Clinigen Group plc ("Clinigen") and the board of directors of Triley Bidco Limited ("Bidco") are pleased to announce that they have agreed the terms of a recommended all-cash acquisition of Clinigen by Bidco, a newly-incorporated company indirectly owned by the Triton Funds pursuant to which Bidco will acquire the entire issued and to be issued ordinary share capital of Clinigen (the “Acquisition”) to be effected by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006.
Further documentation relating to the Acquisition can be found on the website https://announcements.triton-partners.com/announcements
